The prevalence of mild cognitive impairment in breast cancer patients receiving chemotherapy according to the criteria of the National Institute on Aging-Alzheimer's Association (NIA-AA). - Albers EAC; Kieffer JM; Schagen SB (Journal of cancer survivorship : research and practice, 2025)